IT1269880B - Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono - Google Patents

Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono

Info

Publication number
IT1269880B
IT1269880B ITMI941135A ITMI941135A IT1269880B IT 1269880 B IT1269880 B IT 1269880B IT MI941135 A ITMI941135 A IT MI941135A IT MI941135 A ITMI941135 A IT MI941135A IT 1269880 B IT1269880 B IT 1269880B
Authority
IT
Italy
Prior art keywords
extracts
formulations
contain
thonningii
piliostigma
Prior art date
Application number
ITMI941135A
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Giuseppe Mustich
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of ITMI941135A0 publication Critical patent/ITMI941135A0/it
Priority to ITMI941135A priority Critical patent/IT1269880B/it
Priority to FI943295A priority patent/FI943295A7/fi
Priority to CA002127762A priority patent/CA2127762A1/en
Priority to PT94110861T priority patent/PT685235E/pt
Priority to DE0685235T priority patent/DE685235T1/de
Priority to ES94110861T priority patent/ES2081782T3/es
Priority to AT94110861T priority patent/ATE189604T1/de
Priority to DE69422980T priority patent/DE69422980T2/de
Priority to EP94110861A priority patent/EP0685235B1/en
Priority to US08/274,407 priority patent/US5635185A/en
Priority to DK94110861T priority patent/DK0685235T3/da
Priority to AU67517/94A priority patent/AU684781B2/en
Priority to JP6172543A priority patent/JPH07330788A/ja
Priority to KR1019950013949A priority patent/KR100235685B1/ko
Publication of ITMI941135A1 publication Critical patent/ITMI941135A1/it
Priority to GR960300005T priority patent/GR960300005T1/el
Application granted granted Critical
Publication of IT1269880B publication Critical patent/IT1269880B/it
Priority to HK98113938.1A priority patent/HK1012567B/en
Priority to GR20000400290T priority patent/GR3032621T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

La presente invenzione riguarda nuovi estratti di Piliostigma thonningii Schum, dotati di azione antivirale, il procedimento per la loro preparazione, il loro uso in campo terapeutico e formulazioni contenenti questi estratti. Questi nuovi estratti trovano applicazione nel trattamento di patologie di origine virale quali quelle erpetiche, influenzali e broncopolmonari e si sono dimostrati inoltre attivi anche sul virus HIV.
ITMI941135A 1994-06-01 1994-06-01 Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono IT1269880B (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
ITMI941135A IT1269880B (it) 1994-06-01 1994-06-01 Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono
FI943295A FI943295A7 (fi) 1994-06-01 1994-07-11 Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit
CA002127762A CA2127762A1 (en) 1994-06-01 1994-07-11 Extracts from piliostigma thonningii, the use thereof and formulations containing them
EP94110861A EP0685235B1 (en) 1994-06-01 1994-07-13 Extracts of piliostigma thonningii, the use thereof and formulations containing them
DE0685235T DE685235T1 (de) 1994-06-01 1994-07-13 Extrakte von Piliostigma thonningii, deren Verwendung und diese enthaltende Zubereitungen.
ES94110861T ES2081782T3 (es) 1994-06-01 1994-07-13 Extractos procedentes de piliostigma thonningil, su uso y formulaciones que los contienen.
AT94110861T ATE189604T1 (de) 1994-06-01 1994-07-13 Extrakte von piliostigma thonningii, deren verwendung und diese enthaltende zubereitungen
DE69422980T DE69422980T2 (de) 1994-06-01 1994-07-13 Extrakte von Piliostigma thonningii, deren Verwendung und diese enthaltende Zubereitungen
PT94110861T PT685235E (pt) 1994-06-01 1994-07-13 Extractos de piliostigma thonningii, sua utilizacao e formulacoes que os contem
US08/274,407 US5635185A (en) 1994-06-01 1994-07-13 Extracts of Piliostigma thonningii, the use thereof and formulations containing them
DK94110861T DK0685235T3 (da) 1994-06-01 1994-07-13 Ekstrakter af Piliostigma thonningii, anvendelse heraf og formuleringer, som indeholder dem
AU67517/94A AU684781B2 (en) 1994-06-01 1994-07-15 Extracts of piliostigma thonningii, the use thereof and formulations containing them
JP6172543A JPH07330788A (ja) 1994-06-01 1994-07-25 ピリオスティグマ・トニンギイの抽出物、その製造法、ならびに抗ウイルス剤
KR1019950013949A KR100235685B1 (ko) 1994-06-01 1995-05-30 필리오스티그마 톤닌지의 추출물, 그 이용방법 및 그것을 포함하는 조성물
GR960300005T GR960300005T1 (en) 1994-06-01 1996-02-29 Extracts of piliostigma thonningii, the use thereof and formulations containing them.
HK98113938.1A HK1012567B (en) 1994-06-01 1998-12-17 Extracts of piliostigma thonningii, the use thereof and formulations containing them
GR20000400290T GR3032621T3 (en) 1994-06-01 2000-02-10 Extracts of piliostigma thonningii, the use thereof and formulations containing them.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941135A IT1269880B (it) 1994-06-01 1994-06-01 Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono

Publications (3)

Publication Number Publication Date
ITMI941135A0 ITMI941135A0 (it) 1994-06-01
ITMI941135A1 ITMI941135A1 (it) 1995-12-01
IT1269880B true IT1269880B (it) 1997-04-15

Family

ID=11369029

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI941135A IT1269880B (it) 1994-06-01 1994-06-01 Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono

Country Status (14)

Country Link
US (1) US5635185A (it)
EP (1) EP0685235B1 (it)
JP (1) JPH07330788A (it)
KR (1) KR100235685B1 (it)
AT (1) ATE189604T1 (it)
AU (1) AU684781B2 (it)
CA (1) CA2127762A1 (it)
DE (2) DE69422980T2 (it)
DK (1) DK0685235T3 (it)
ES (1) ES2081782T3 (it)
FI (1) FI943295A7 (it)
GR (2) GR960300005T1 (it)
IT (1) IT1269880B (it)
PT (1) PT685235E (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003026636A (ja) * 2001-07-10 2003-01-29 Gekkeikan Sake Co Ltd 脂質代謝系酵素を阻害するチロゾール誘導体
CN108619178B (zh) * 2018-06-08 2021-04-09 临沂大学 一种具有抗病毒作用的忍冬藤菇提取物及其制备方法和应用

Also Published As

Publication number Publication date
CA2127762A1 (en) 1995-12-02
FI943295L (fi) 1995-12-02
GR3032621T3 (en) 2000-05-31
ATE189604T1 (de) 2000-02-15
KR100235685B1 (ko) 2000-02-01
KR960000244A (ko) 1996-01-25
GR960300005T1 (en) 1996-02-29
US5635185A (en) 1997-06-03
ES2081782T3 (es) 2000-07-01
ES2081782T1 (es) 1996-03-16
AU6751794A (en) 1996-01-04
AU684781B2 (en) 1998-01-08
JPH07330788A (ja) 1995-12-19
PT685235E (pt) 2000-05-31
DE69422980T2 (de) 2000-08-17
DE685235T1 (de) 1996-10-10
ITMI941135A1 (it) 1995-12-01
DE69422980D1 (de) 2000-03-16
HK1012567A1 (en) 1999-08-06
EP0685235B1 (en) 2000-02-09
FI943295A0 (fi) 1994-07-11
FI943295A7 (fi) 1995-12-02
EP0685235A1 (en) 1995-12-06
DK0685235T3 (da) 2000-06-19
ITMI941135A0 (it) 1994-06-01

Similar Documents

Publication Publication Date Title
YU7296A (sh) Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida
FI20001231A7 (fi) 2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
ES541103A0 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
PT933993E (pt) Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
ES2186714T3 (es) Uso de sustipo simple alpha 8 en la preparacion de medicamentos para el tratamiento de infecciones virales del higado.
BR0209777A (pt) Formulações lìquidas estáveis
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
EA199901031A1 (ru) Производные бензимидазола
BRPI0411900A (pt) compostos antivirais e métodos
IT1256450B (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
ES2061453T3 (es) Composiciones farmaceuticas antivirales que contienen hipericina o pseudohipericina.
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
ATA18952001A (de) Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AU8193191A (en) Method of using cold-adapted live influenza virus vaccine as an antiviral agent against influenza
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
ES2060147T3 (es) Nuevas emulsiones acuosas concentradas, su procedimiento de preparacion y su aplicacion en el campo plaguicida.
IT1269880B (it) Estratti di piliostigma thonningii, loro uso e formulazioni che li contengono
ATE401901T1 (de) Antikrebs- und antivirale zusammensetzung
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
TR199900523T2 (xx) Vir�s k�kenli hastal�klar�n tedavisi i�in farmas�tik bile�imler.
ES2121109T3 (es) Composicion de champu.
MX9700044A (es) Combinacion triple anti-virus de inmunodeficiencia humana.
IT1270008B (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
MX9303743A (es) Derivados de indolizinas, procedimiento para preparacion y su empleo para la preparacion de compu estos de aminoalcoxibencensulfonil-indolizinas.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970626